Metabolic phenotype of rats exposed to heroin and potential markers of heroin abuse

Drug and Alcohol Dependence

Volumn 127, Issue 1-3, 2013, Pages 177-186

  Zheng, Tian ^a,b   Liu, Linsheng ^a   Aa, Jiye ^a   Wang, Guangji ^a   Cao, Bei ^a   Li, Mengjie ^a   Shi, Jian ^a   Wang, Xinwen ^a   Zhao, Chunyan ^a   Gu, Rongrong ^a   Zhou, Jun ^a   Xiao, Wenjing ^a   Yu, Xiaoyi ^a   Sun, Runbing ^a   Zhou, Yahong ^b   Zuo, Yuexian ^c   Zhu, Xuanxuan ^d  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b Jiangsu Police Institute   (China)

^c Nanjing Municipal Public Security Bureau   (China)

^d AFFILIATED HOSPITAL OF NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Gas chromatography time of flight mass spectrometry; Heroin; Metabolic effect; Metabolomics

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; AMINO ACID; DIAMORPHINE; FATTY ACID; HYDROXYPROLINE; INOSITOL PHOSPHATE; SEROTONIN; THREONATE; TRICARBOXYLIC ACID; TRYPTOPHAN; UNCLASSIFIED DRUG;

ADAPTIVE BEHAVIOR; AMINO ACID BLOOD LEVEL; AMINO ACID METABOLISM; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR DISORDER; BLOOD; BLOOD ANALYSIS; CARBOHYDRATE METABOLISM; CITRIC ACID CYCLE; CONTROLLED STUDY; FATTY ACID METABOLISM; HEROIN DEPENDENCE; MALE; MASS FRAGMENTOGRAPHY; METABOLOMICS; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONIN BLOOD LEVEL; URINALYSIS; URINE; WEIGHT REDUCTION;

ANIMALS; BIOLOGICAL MARKERS; ENERGY METABOLISM; HEROIN; HEROIN DEPENDENCE; INJECTIONS, INTRAPERITONEAL; MALE; METABOLOMICS; PHENOTYPE; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY;

RATTUS;

EID: 84870949381     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2012.06.031     Document Type: Article

References (30)

1. A J., Huang Q., Wang G., Zha W., Yan B., Ren H., Gu S., Zhang Y., Zhang Q., Shao F., Sheng L., Sun J. Global analysis of metabolites in rat and human urine based on gas chromatography/time-of-flight mass spectrometry. Anal. Biochem. 2008, 379:20-26.
2. Aa J., Shao F., Wang G., Huang Q., Zha W., Yan B., Zheng T., Liu L., Cao B., Shi J., Li M., Zhao C., Wang X., Wu Z. Gas chromatography time-of-flight mass spectrometry based metabolomic approach to evaluating toxicity of triptolide. Metabolomics 2011, 7:217-225.
3. Beck T., Wenzel J., Kuschinsky K., Krieglstein J. Morphine-induced alterations of local cerebral glucose utilization in the basal ganglia of rats. Brain Res. 1989, 497:205-213.
4. Bhakthan N.M., Chiu S. Deranged diurnal feeding pattern and altered brain serotonin turnover in heroin-dependent rats. Arch. Int. Pharmacodyn. Ther. 1978, 235:289-298.
5. Corrigall W.A., Coen K.M. Selective D1 and D2 dopamine antagonists decrease response rates of food-maintained behavior and reduce the discriminative stimulus produced by heroin. Pharmacol. Biochem. Behav. 1990, 35:351-355.
6. Cunha-Oliveira T., Rego A.C., Garrido J., Borges F., Macedo T., Oliveira C.R. Street heroin induces mitochondrial dysfunction and apoptosis in rat cortical neurons. J. Neurochem. 2007, 101:543-554.
7. Desole M.S., Esposito G., Fresu L., Migheli R., Enrico P., Mura M.A., De Natale G., Miele E., Miele M. Effects of morphine treatment and withdrawal on striatal and limbic monoaminergic activity and ascorbic acid oxidation in the rat. Brain Res. 1996, 723:154-161.
8. Di Daniel E., Kew J.N., Maycox P.R. Investigation of the H(+)-myo-inositol transporter (HMIT) as a neuronal regulator of phosphoinositide signalling. Biochem. Soc. Trans. 2009, 37:1139-1143.
9. Multi- and Megavariate Data Analysis Principles and Applications 2001, Umetrics AB, Umea, Sweden. L. Eriksson, E. Johansson, N. Kettaneh-Wold, S. Wold (Eds.).
10. Inturrisi C.E., Max M.B., Foley K.M., Schultz M., Shin S.U., Houde R.W. The pharmacokinetics of heroin in patients with chronic pain. N. Engl. J. Med. 1984, 310:1213-1217.
11. Inturrisi C.E., Schultz M., Shin S., Umans J.G., Angel L., Simon E.J. Evidence from opiate binding studies that heroin acts through its metabolites. Life Sci. 1983, 33(Suppl. 1):773-776.
12. Johnson S.W., North R.A. Opioids excite dopamine neurons by hyperpolarization of local interneurons. J. Neurosci. 1992, 12:483-488.
13. Jonsson P., Johansson A.I., Gullberg J., Trygg J., Jiye A., Grung B., Marklund S., Sjostrom M., Antti H., Moritz T. High-throughput data analysis for detecting and identifying differences between samples in GC/MS-based metabolomic analyses. Anal. Chem. 2005, 77:5635-5642.
14. Kaddurah-Daouk R., Kristal B.S., Weinshilboum R.M. Metabolomics: a global biochemical approach to drug response and disease. Annu. Rev. Pharmacol. Toxicol. 2008, 48:653-683.
15. Keun H.C., Athersuch T.J. Application of metabonomics in drug development. Pharmacogenomics 2007, 8:731-741.
16. Kish S.J., Kalasinsky K.S., Derkach P., Schmunk G.A., Guttman M., Ang L., Adams V., Furukawa Y., Haycock J.W. Striatal dopaminergic and serotonergic markers in human heroin users. Neuropsychopharmacology 2001, 24:561-567.
17. Kuriyama K., Yoneda Y. Morphine induced alterations of gamma-aminobutyric acid and taurine contents and l-glutamate decarboxylase activity in rat spinal cord and thalamus: possible correlates with analgesic action of morphine. Brain Res. 1978, 148:163-179.
18. LaLumiere R.T., Kalivas P.W. Glutamate release in the nucleus accumbens core is necessary for heroin seeking. J. Neurosci. 2008, 28:3170-3177.
19. Liu L., Aa J., Wang G., Yan B., Zhang Y., Wang X., Zhao C., Cao B., Shi J., Li M., Zheng T., Zheng Y., Hao G., Zhou F., Sun J., Wu Z. Differences in metabolite profile between blood plasma and serum. Anal. Biochem. 2010, 406:105-112.
20. Mannelli P., Patkar A., Rozen S., Matson W., Krishnan R., Kaddurah-Daouk R. Opioid use affects antioxidant activity and purine metabolism: preliminary results. Hum. Psychopharmacol. 2009, 24:666-675.
21. Mao J., Sung B., Ji R., Lim G. Chronic morphine induces down-regulation of spinal glutamate transporters: implications in morphine tolerance and abnormal pain sensitivity. J. Neurosci. 2002, 22:8312-8323.
22. Nicholson J.K., Lindon J.C., Holmes E. 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 1999, 29:1181-1189.
23. + evoked glutamate release from rat cerebrocortical slices. Neurosci. Lett. 1996, 218:79-82.
24. Ning M., Ying L., Nan L., ChangXin W., Hao Z., XiaoFeng J., HuSheng X., XianMing F., Xiaoping H., DaRen Z. Addiction related alteration in resting-state brain connectivity. NeuroImage 2009, 49:738-744.
25. Oldendorf W.H., Hyman S., Braun L., Oldendorf S.Z. Blood-brain barrier: penetration of morphine, codeine, heroin, and methadone after carotid injection. Science 1972, 178:984-986.
26. Patkar A.A., Rozen S., Mannelli P., Matson W., Pae C.U., Krishnan K.R., Kaddurah-Daouk R. Alterations in tryptophan and purine metabolism in cocaine addiction: a metabolomic study. Psychopharmacology (Berl.) 2009, 206:479-489.
27. Ryan A., Molloy F.M., Farrell M.A., Hutchinson M. Fatal toxic leukoencephalopathy: clinical, radiological, and necropsy findings in two patients. J. Neurol. Neurosurg. Psychiatry 2005, 76:1014-1016.
28. Trygg J., Holmes E., Lundstedt T. Chemometrics in metabonomics. J. Proteome Res. 2007, 6:469-479.
29. Wold S. Cross-validatory estimation of the number of components in factor and principal components models. Technometrics 1978, 20:397-405.
30. Xu N.J., Bao L., Fan H.P., Bao G.B., Pu L., Lu Y.J., Wu C.F., Zhang X., Pei G. Morphine withdrawal increases glutamate uptake and surface expression of glutamate transporter GLT1 at hippocampal synapses. J. Neurosci. 2003, 23:4775-4784.